Pritesh P. Shah
Lawyers
Filters
Davis Polk Advises Emerson on the Acquisition of Valves & Controls Business from Pentair
Davis Polk is advising Emerson Electric Co. on the $3.15 billion acquisition of the Valves & Controls business of Pentair. The acquisition is expected to close in the next four to six…
Davis Polk Advises MSCI Inc. on Its $500 Million Notes Offering and Amendment to Revolving Credit Agreement
Davis Polk advised MSCI Inc. (“MSCI”) in connection with a Rule 144A/Regulation S offering of $500 million aggregate principal amount of its 4.750% senior notes due 2026 and a concurrent…
Davis Polk Advises Aetna on the Sale of Medicare Advantage Assets to Molina Healthcare
Davis Polk is advising Aetna Inc. in connection with the sale by Aetna and Humana Inc. of certain of their respective Medicare Advantage assets to Molina Healthcare, Inc. for a total…
Davis Polk Advises Emerson on the Sale of Its Network Power Division to Platinum Equity
Davis Polk is advising Emerson Electric Co. on the sale of its Network Power division to Platinum Equity Advisors, LLC and a group of co-investors. The transaction is valued at $4 billion…
PerkinElmer, Inc. €500 Million Notes Offering
Davis Polk advised the joint book-running managers in connection with an offering by PerkinElmer, Inc. of €500 million aggregate principal amount of its 1.875% notes due 2026.
Headquartered…
Davis Polk Advises Cube Hydro on Its Acquisition of Hydroelectric Plants on the Yadkin River in North Carolina
Davis Polk is advising Cube Hydro Carolinas LLC, an affiliate of Cube Hydro Partners, LLC, in connection with its agreement to purchase and upgrade four hydroelectric power plants located…
Molson Coors $7 Billion Concurrent Offerings of U.S. Dollar, Euro and Canadian Dollar-Denominated Notes
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by Molson Coors Brewing Company (“Molson Coors”) of (i) $500 million…
Global Blood Therapeutics, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $120 million follow-on offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock is…
Under Armour, Inc. $600 Million Senior Notes Offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by Under Armour, Inc. of $600 million aggregate principal amount of its 3…
Davis Polk Advises Solvay on the Buyout of Its Joint Venture with Eastman Chemical Company
Davis Polk is advising Solvay SA in connection with its acquisition of the remaining 50% interest in Primester, a joint venture partnership between Solvay and Eastman Chemical Company…